DOI QR코드

DOI QR Code

신생아 급성 신부전의 치료

Treatment of Acute Renal Failure in Neonate

  • 이진아 (서울대학교 의과대학 소아과학교실)
  • Lee, Jin-A (Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine)
  • 발행 : 2010.11.30

초록

Acute renal failure (ARF) is common in the neonatal period, however, there are no uniform treatment strategies of ARF. The main treatment strategies are conservative management including medical treatment and the renal replacement therapy. Because ARF in the newborn is commonly acquired by hypoxic ischemic injury and toxic insults, removal of all the offending causes is important. Aminoglycoside, indomethacin, and amphotericin-B are the most common nephrotoxic drugs of ARF. To relieve the possible prerenal ARF, initial fluid challenge can be followed by diuretics. If there is no response, fluid restriction and correction of electrolyte imbalance should begin. Adequate nutritional support and drug dosing according to the pharmacokinetics of such drugs will be difficult problems. Renal replacement therapies may be provided by peritoneal dialysis, intermittent hemodialysis, or hemofiltration. New promising agents, bioartificial kidney, and stem cell will enable us to extend our therapeutic repertoire.

키워드

참고문헌

  1. Andreoli SP. Acute renal failure in the newborn. Semin Perinatol 2004;28:112-23. https://doi.org/10.1053/j.semperi.2003.11.003
  2. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001;281:F887-99. https://doi.org/10.1152/ajprenal.00050.2001
  3. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31. https://doi.org/10.1186/cc5713
  4. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12. https://doi.org/10.1186/cc2872
  5. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007;71:1028-35. https://doi.org/10.1038/sj.ki.5002231
  6. Askenazi DJ, Ambalavanan N, Goldstein SL. Acute kidney injury in critically ill newborns: what do we know? What do we need to learn? Pediatr Nephrol 2009;24:265-74. https://doi.org/10.1007/s00467-008-1060-2
  7. Ronco C, Bellomo R, Kellum JA. Critical care nephrology in pediatrics. In: Ronco C, Bellomo R, Kellum JA, editors. Critical care nephrology. 2nd ed. Philadelphia: Saunders/Elsevier, 2009.
  8. Allegaert K, Vanhole C, de Hoon J, Guignard JP, Tibboel D, Devlieger H, et al. Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates. Pediatr Nephrol 2005;20:1557-61. https://doi.org/10.1007/s00467-005-1998-2
  9. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010:CD003481.
  10. Prins I, Plötz FB, Uiterwaal CS, van Vught HJ. Low-dose dopamine in neonatal and pediatric intensive care: a systematic review. Intensive Care Med 2001;27:206-10. https://doi.org/10.1007/s001340000775
  11. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001;29:1526-31. https://doi.org/10.1097/00003246-200108000-00005
  12. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Lowdose dopamine in patients with early renal dysfunction: a placebocontrolled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000;356: 2139-43. https://doi.org/10.1016/S0140-6736(00)03495-4
  13. Lauschke A, Teichgräber UK, Frei U, Eckardt KU. 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006;69:1669-74. https://doi.org/10.1038/sj.ki.5000310
  14. Albanèse J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004;126:534-9. https://doi.org/10.1378/chest.126.2.534
  15. Marshall J, Berkenbosch JW, Russo P, Tobias JD. Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med 2004;19:164-70. https://doi.org/10.1177/0885066604263828
  16. Moffett BS, Mott AR, Nelson DP, Goldstein SL, Jefferies JL. Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review. Pediatr Crit Care Med 2008;9:403-6. https://doi.org/10.1097/PCC.0b013e3181728c25
  17. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56. https://doi.org/10.1056/NEJMoa040232
  18. Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med 2006;34:2536-40. https://doi.org/10.1097/01.CCM.0000239119.57544.0C
  19. Moghal NE, Shenoy M. Furosemide and acute kidney injury in neonates. Arch Dis Child Fetal Neonatal Ed 2008;93:F313-6.
  20. Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010;55:316-25. https://doi.org/10.1053/j.ajkd.2009.10.048
  21. Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD, Blowey D, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005;67:653-8. https://doi.org/10.1111/j.1523-1755.2005.67121.x
  22. Moghal NE, Embleton ND. Management of acute renal failure in the newborn. Semin Fetal Neonatal Med 2006;11:207-13. https://doi.org/10.1016/j.siny.2006.01.007
  23. Kiessling SG, Goebel J, Somers MJG. Acute kidney injury. In : Pediatric nephrology in the ICU. Berlin: Springer, 2009.
  24. Jenik AG, Ceriani Cernadas JM, Gorenstein A, Ramirez JA, Vain N, Armadans M, et al. A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 2000;105:E45. https://doi.org/10.1542/peds.105.4.e45
  25. Bakr AF. Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia--a study in a developing country. Pediatr Nephrol 2005;20:1249-52. https://doi.org/10.1007/s00467-005-1980-z
  26. Yu JE, Park MS, Pai KS. Acute peritoneal dialysis in very low birth weight neonates using a vascular catheter. Pediatr Nephrol 2010;25:367-71. https://doi.org/10.1007/s00467-009-1347-y
  27. Kunzendorf U, Haase M, Rölver L, Haase-Fielitz A. Novel aspects of pharmacological therapies for acute renal failure. Drugs 2010;70: 1099-114. https://doi.org/10.2165/11535890-000000000-00000
  28. Fliser D, Bahlmann FH, Haller H. EPO: renoprotection beyond anemia correction. Pediatr Nephrol 2006;21:1785-9. https://doi.org/10.1007/s00467-006-0284-2
  29. Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010;77:1020-30. https://doi.org/10.1038/ki.2010.25
  30. Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009; 30:253-60. https://doi.org/10.1159/000223229
  31. Kien ND, Moore PG, Jaffe RS. Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs. Anesth Analg 1992;74:72-8.
  32. Tumlin JA. Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy. Curr Opin Crit Care 2009;15:514-9. https://doi.org/10.1097/MCC.0b013e328332f6f9
  33. Costello JM, Thiagarajan RR, Dionne RE, Allan CK, Booth KL, Burmester M, et al. Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med 2006;7:28-33. https://doi.org/10.1097/01.PCC.0000194046.47306.FB
  34. Yoder SE, Yoder BA. An evaluation of off-label fenoldopam use in the neonatal intensive care unit. Am J Perinatol 2009;26:745-50. https://doi.org/10.1055/s-0029-1223288
  35. Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S, et al. Phase II, randomized, controlled trial of highdose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007;35:1324-31. https://doi.org/10.1097/01.CCM.0000261887.69976.12
  36. Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009;4:261-72. https://doi.org/10.2215/CJN.03780808
  37. Song JH, Humes HD. The bioartificial kidney in the treatment of acute kidney injury. Curr Drug Targets 2009;10:1227-34. https://doi.org/10.2174/138945009789753273
  38. Imai N, Kaur T, Rosenberg ME, Gupta S. Cellular therapy of kidney diseases. Semin Dial 2009;22:629-35. https://doi.org/10.1111/j.1525-139X.2009.00654.x
  39. Chhabra P, Brayman KL. The use of stem cells in kidney disease. Curr Opin Organ Transplant 2009;14:72-8. https://doi.org/10.1097/MOT.0b013e328320d2f5

피인용 문헌

  1. Antimicrobial Management of Neonatal Sepsis vol.19, pp.2, 2010, https://doi.org/10.5385/jksn.2012.19.2.53
  2. Continuous Renal Replacement Therapy in the Neonatal Intensive Care Unit: A Single-Center Study vol.21, pp.4, 2010, https://doi.org/10.5385/nm.2014.21.4.244